ACHC vs. HQY, ENSG, BPMC, EXEL, STVN, ITCI, JAZZ, RVMD, MASI, and CYTK
Should you be buying Acadia Healthcare stock or one of its competitors? The main competitors of Acadia Healthcare include HealthEquity (HQY), The Ensign Group (ENSG), Blueprint Medicines (BPMC), Exelixis (EXEL), Stevanato Group (STVN), Intra-Cellular Therapies (ITCI), Jazz Pharmaceuticals (JAZZ), Revolution Medicines (RVMD), Masimo (MASI), and Cytokinetics (CYTK). These companies are all part of the "medical" sector.
HealthEquity (NASDAQ:HQY) and Acadia Healthcare (NASDAQ:ACHC) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk, community ranking and dividends.
HealthEquity has higher earnings, but lower revenue than Acadia Healthcare. Acadia Healthcare is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.
99.6% of HealthEquity shares are held by institutional investors. 2.7% of HealthEquity shares are held by insiders. Comparatively, 2.0% of Acadia Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Acadia Healthcare received 45 more outperform votes than HealthEquity when rated by MarketBeat users. However, 69.24% of users gave HealthEquity an outperform vote while only 66.75% of users gave Acadia Healthcare an outperform vote.
HealthEquity has a net margin of 5.57% compared to HealthEquity's net margin of -0.38%. HealthEquity's return on equity of 11.49% beat Acadia Healthcare's return on equity.
In the previous week, Acadia Healthcare had 6 more articles in the media than HealthEquity. MarketBeat recorded 16 mentions for Acadia Healthcare and 10 mentions for HealthEquity. Acadia Healthcare's average media sentiment score of 1.26 beat HealthEquity's score of 0.41 indicating that HealthEquity is being referred to more favorably in the media.
HealthEquity has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500. Comparatively, Acadia Healthcare has a beta of 1.31, suggesting that its share price is 31% more volatile than the S&P 500.
HealthEquity currently has a consensus target price of $96.17, indicating a potential upside of 21.41%. Acadia Healthcare has a consensus target price of $87.56, indicating a potential upside of 31.96%. Given HealthEquity's higher possible upside, analysts clearly believe Acadia Healthcare is more favorable than HealthEquity.
Summary
HealthEquity beats Acadia Healthcare on 11 of the 18 factors compared between the two stocks.
Get Acadia Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for ACHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ACHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Acadia Healthcare Competitors List
Related Companies and Tools
